Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550470 · ClinicalTrials.gov registry record
Evaluation of Micropore"s SpiraLith Absorbents
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 186
- Enrollment target
NCT02550470 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 186 participants.
The verdict
NCT02550470 has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 186 participants
- Enrollment target
Study Summary
This is an observational study investigating the duration of use and cost of the new CO2 absorbent Micropore's Spiralith®, compared to Drägersorb® 800+, Drägersorb® Free.
Interventions
- DRUG Sevoflurane
- DEVICE Carbon Dioxide Absorbents
- DEVICE Micropore SpiraLith
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02550470
The ClinicalTrials.gov registry entry for NCT02550470 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sevoflurane is the first listed.
NCT02550470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02550470 about?
NCT02550470 is a clinical study titled "Evaluation of Micropore"s SpiraLith Absorbents". This is an observational study investigating the duration of use and cost of the new CO2 absorbent Micropore's Spiralith®, compared to Drägersorb® 800+, Drägersorb® Free.
What is the current status of trial NCT02550470?
This trial is currently completed. The enrollment target is 186 participants. The study started on 2015-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02550470?
The interventions under investigation include: Sevoflurane (DRUG), Carbon Dioxide Absorbents (DEVICE), Micropore SpiraLith (DEVICE).
Who is sponsoring clinical trial NCT02550470?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.